With so many products on the market, you might think balding is curable, but there are few treatments that will actually work ...

The FDA has approved Novo Nordisk’s oral Wegovy, marking the first pill-form GLP-1 drug for chronic weight management in the ...

Columnist Sam Kirton explores what options are available to help IPF patients meet the costs of their medical care and medications.

Surescripts®, the nation’s leading health intelligence network, introduces its Patient Experience product, Script Corner™, to ...

Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the ...